In the latest trading session,, 0.45 million Applied Therapeutics Inc (NASDAQ:APLT) shares changed hands as the company’s beta touched 1.84. With the company’s most recent per share price at $0.33 changing hands around $0.01 or 0.91% at last look, the market valuation stands at $46.26M. APLT’s current price is a discount, trading about -3118.18% off its 52-week high of $10.62. The share price had its 52-week low at $0.29, which suggests the last value was 12.12% up since then. When we look at Applied Therapeutics Inc’s average trading volume, we note the 10-day average is 3.0 million shares, with the 3-month average coming to 2.41 million.
Analysts gave the Applied Therapeutics Inc (APLT) stock a consensus recommendation rating of Buy, calculated at a mean rating of 2.25. If we narrow down to specifics, the data shows that 0 out of 3 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended APLT as a Hold, 3 felt it is a Buy and 0 rated the stock as Underweight.
Applied Therapeutics Inc (NASDAQ:APLT) trade information
Instantly APLT is in green as seen in intraday trades today. With action 8.92%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -92.67%, with the 5-day performance at 8.92% in the green. However, in the 30-day time frame, Applied Therapeutics Inc (NASDAQ:APLT) is -9.36% down. Looking at the short shares, we see there were 21.33 million shares sold at short interest cover period of 8.79 days.
The consensus price target for the stock as assigned by Wall Street analysts is 4.5, meaning bulls need an upside of 92.67% from its recent market value. According to analyst projections, APLT’s forecast low is 4 with 5 as the target high. To hit the forecast high, the stock’s price needs a -1415.15% plunge from its current level, while the stock would need to soar -1112.12% for it to hit the projected low.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 26.57%. The 2025 estimates are for Applied Therapeutics Inc earnings to increase by 23.30%, but the outlook for the next 5-year period is at 34.33% per year.
APLT Dividends
Applied Therapeutics Inc is expected to release its next quarterly earnings report on 2025-May-13.
Applied Therapeutics Inc (NASDAQ:APLT)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 5.49% of Applied Therapeutics Inc shares while 83.05% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 87.87%. There are 83.05% institutions holding the Applied Therapeutics Inc stock share, with FRANKLIN RESOURCES INC the top institutional holder. As of 2024-06-30, the company held 70.7533% of the shares, roughly 10.21 million APLT shares worth $47.69 million.
VR ADVISER, LLC holds the second largest percentage of outstanding shares, with 66.1112% or 9.54 million shares worth $44.57 million as of 2024-06-30.
Among Mutual Funds, the top two as of Mar 31, 2025 were T. Rowe Price Small-Cap Value Fund, Inc. and Simplify Exchange Traded Funds-Simplify Propel Opportunities ETF . With 6.47 shares estimated at $2.15 million under it, the former controlled 4.57% of total outstanding shares. On the other hand, Simplify Exchange Traded Funds-Simplify Propel Opportunities ETF held about 3.17% of the shares, roughly 4.49 shares worth around $1.49 million.
